Medication info
Januglo 50 mg (Sitagliptin Hydrochloride Hydrate)

Januglo 50 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.69mg / 1 tablet
Manufacturer / importer
Samchundang Pharm Co., Ltd.
Appearance
Bright yellow-orange circular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202301961 · Approved 2023.06.27 · Insurance code 651206060

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medication, whether used as monotherapy or in combination therapy, is 100 mg once daily. The maximum daily dose is 100 mg. This medication may be taken with or without food. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function before treatment and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Samchundang Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to help improve blood sugar control in patients with type 2 diabetes. Initially, it can be given alone along with diet and exercise therapy. If there is no prior experience of diabetes treatment and blood sugar control is difficult with monotherapy, it can be taken in conjunction with metformin. Additionally, it is added for combination therapy when blood sugar control is difficult with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin. When multiple drugs are used in combination, this medication helps enhance blood sugar control. Therefore, it is effectively used to improve blood sugar control in type 2 diabetes.

Dosage and Administration

Adult dosage

The recommended dose of this medication, whether used as monotherapy or in combination therapy, is 100 mg once daily. The maximum daily dose is 100 mg. This medication may be taken with or without food. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function before treatment and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration; therefore, if symptoms such as skin rash or difficulty breathing occur, it should be discontinued immediately and a physician should be consulted. Furthermore, during the use of this medication, serious pancreatitis may develop, so if symptoms such as abdominal pain or vomiting occur, it should be reported to medical personnel immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also be avoided in cases of hypersensitivity to this medication or its ingredients. Patients with impaired renal function may have difficulty excreting this medication; thus, the dosage should be carefully adjusted. This medication can cause hypoglycemia when used alone or in combination with other diabetes medications, so caution must be taken to monitor for hypoglycemic symptoms when taken with insulin or sulfonylureas. Severe joint pain may occur during medication use; therefore, if such symptoms develop, a physician should be consulted to determine whether to discontinue the medication. A rare skin disease called bullous pemphigoid has been reported; if blisters or erosions develop on the skin, a physician should be notified immediately. It is not recommended for use in pregnant or nursing women, and safety in children under 18 years of age has not been established, so use should be approached with caution. Elderly patients may experience reduced renal function; therefore, dosage adjustment and renal function tests are necessary. In cases of overdose, general supportive treatment is required; this medication can be partially removed by hemodialysis, so patients should receive treatment according to medical personnel's instructions. Lastly, interactions with other medications are generally rare, but when taken with certain medications, it is important to inform medical personnel and adjust medications if needed.

Side effects

  • Severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
Show 35 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased ALT
  • increased AST
  • elevated serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be maintained for a long time.

Appearance and packaging

Appearance

Bright yellow-orange circular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.